Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts

Background: Although a substantial decline in vaccine-serotype invasive pneumococcal disease (IPD) incidence was observed following the introduction of pneumococcal conjugate vaccines (PCV), the estimated range of thirteen-valent conjugate vaccine (PCV13) effectiveness for serotype 3 disease is wide...

詳細記述

書誌詳細

主要な著者:	Rotem Lapidot, Kimberly M. Shea, Inci Yildirim, Howard J. Cabral, Stephen I. Pelton, the Massachusetts Department of Public Health
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2020-05-01
シリーズ:	Pathogens
主題:	<i>Streptococcus pneumoniae serotype 3</i> PCV13 invasive pneumococcal disease
オンライン･アクセス:	https://www.mdpi.com/2076-0817/9/5/396
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!